Arcion Therapeutics
Latest round
- Series A
Last raised
- Dec 2007
Total raised
- $8M
Investors
- 2
About Arcion Therapeutics
Arcion Therapeutics, Inc.Founded in 2007 and headquartered in Baltimore, US, Arcion Therapeutics, Inc. specializes in biopharmaceuticals.Arcion Therapeutics, Inc. focuses on developing innovative therapeutic solutions for treating complex diseases. Their primary offerings include advanced biopharmaceutical products aimed at addressing unmet medical needs through targeted therapies and research-driven methodologies.The revenue model of Arcion Therapeutics, Inc. is based on contractual agreements with healthcare institutions, centered around their biopharmaceutical solutions. Revenue is generated through partnerships and direct sales, with a structured pricing strategy that accommodates varying scales of service.In the upcoming years, Arcion Therapeutics, Inc. plans to launch new biopharmaceutical products targeting specific diseases, with expected release dates in alignment with ongoing clinical trials.
Who invested in Arcion Therapeutics
2 investors across 1 round
See all investors in Arcion Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 13, 2007
Amount
$8M
Investors
Questions about Arcion Therapeutics
Who invested in Arcion Therapeutics?
Arcion Therapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Arcion Therapeutics raised?
Arcion Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Arcion Therapeutics last raise money?
Arcion Therapeutics's most recent round on record is a Series A, in Dec 2007.
What does Arcion Therapeutics do?
Arcion Therapeutics is a biotechnology company.
Where is Arcion Therapeutics headquartered?
Arcion Therapeutics is headquartered in Baltimore, US.
Which VCs invest in companies like Arcion Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Arcion Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Arcion Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.